Preferred Label : treosulfan;
MeSH note : RN given refers to (S-(R*,R*))-isomer;
CISMeF synonym : C6H14O8S2; NSC 39069;
MeSH synonym : L-dihydroxybusulfan; L-threitol-1,4-bismethanesulfonate;
MeSH CAS label : (S-(R*,R*))- 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate;
MeSH Related Number : treosulfan, (R-(R*,R*))-isomer; treosulfan, (R*,R*)-isomer; treosulfan, (R*,S*)-isomer; treosulfan, ((R*,R*)-( -))-isomer; 13308-13-9 ((R*,S*)-isomer); 1947-62-2 ((R-(R*,R*))-isomer); 21106-06-9 ((R*,R*)-isomer); 299-74-1 (((R*,R*)-( -))-isomer); 299-75-2 (treosulfan);
Libelles Related CAS CISMeF : dinonanoate d'éthylènebis(oxyéthylène);
Registry Number MeSH : 299-75-2;
Related CAS MeSH : 13308-13-9 (treosulfan, (R*,S*)-isomer); 1947-62-2 (treosulfan, (R-(R*,R*))-isomer); 299-74-1 (treosulfan, ((R*,R*)-( -))-isomer); 21106-06-9 (treosulfan, (R*,R*)-isomer);
related registry number list (CISMeF) : 13308-13-9 ((R*,S*)-isomer); 1947-62-2 ((R-(R*,R*))-isomer); 21106-06-9 ((R*,R*)-isomer);
299-74-1 (((R*,R*)-( -))-isomer);
Codes EINECS : 206-081-0;
Is substance : O;
UNII : CO61ER3EPI;
InChIKey : YCPOZVAOBBQLRI-WDSKDSINSA-N;
Origin ID : C018404;
UMLS CUI : C0076959;
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3538216/fr/trecondi-treosulfan-hematologie-greffe
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
transplantation conditioning
fludarabine
child
infant
adolescent
hematopoietic stem cell transplantation
Allogeneic Hematopoietic Stem Cell Transplantation
infusions, intravenous
evaluation of the transparency committee
treosulfan
drug therapy, combination
---
https://www.has-sante.fr/jcms/p_3196682/fr/trecondi
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
treosulfan
treosulfan
infusions, intravenous
drug therapy, combination
fludarabine
transplantation conditioning
hematopoietic stem cell transplantation
allografts
child
infant
adolescent
adult
hematologic neoplasms
treosulfan
busulfan
busulfan
busulfan
vidarabine
vidarabine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/trecondi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treosulfan
treosulfan
transplantation conditioning
hematopoietic stem cell transplantation
allografts
adult
adolescent
infant
child
orphan drug production
infusions, intravenous
drug therapy, combination
antineoplastic agents, alkylating
antineoplastic agents, alkylating
pregnancy
breast feeding
fertility
treosulfan
survival analysis
drug evaluation, preclinical
busulfan
busulfan
busulfan
---